Zolmitriptan and Zomig
Type of Spiritual Experience
A description of the experience
Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches.
Zolmitriptan is marketed with the brand names Zomig, Zomigon (Argentina, Canada & Greece), AscoTop (Germany) and Zomigoro (France).
On Jan, 20, 2017 565 people reported to have side effects when taking Zolmitriptan. Among them, 6 people (1.06%) have Hallucination
On Dec, 30, 2016 137 people reported to have side effects when taking Zomig-zmt. Among them, 1 person (0.73%) has Hallucination
On Jan, 10, 2017 4,498 people reported to have side effects when taking Zomig. Among them, 21 people (0.47%) have Hallucination